Research and Clinical Trials

Using advanced technology, scientists at Mayo Clinic, Chan Zuckerberg (CZ) Biohub and the University of California San Francisco (UCSF), have discovered an autoimmune disease that ...

According to new research from Mayo Clinic, colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more ...

Mayo Clinic has opened a new 190,000-square-foot medical building on its Florida campus for patients seeking cancer, neurology and neurosurgical care. Named in honor of benefactors ...

Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Researchers from Mayo Clinic are evaluating a new, noninvasive screening method for Barrett's esophagus that uses an electronic nose device called an e-nose to analyze ...

Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Results of a study on smoldering multiple myeloma presented at the 2019 American Society of Clinical Oncology Annual Meeting suggest that the cancer drug lenalidomide ...

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and ...

A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most patients ...

The percentage of women who are screened for cervical cancer may actually be far lower than national statistics suggest they are, according to a Mayo ...